{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:20:23Z","timestamp":1778538023090,"version":"3.51.4"},"reference-count":50,"publisher":"Informa UK Limited","issue":"10","funder":[{"name":"National Cancer Institute Awards","award":["K24CA208132"],"award-info":[{"award-number":["K24CA208132"]}]},{"name":"National Cancer Institute Awards","award":["U01CA195568"],"award-info":[{"award-number":["U01CA195568"]}]},{"DOI":"10.13039\/100006316","name":"Alliance for Clinical Trials in Oncology Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006316","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003977","name":"Israeli Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Cancer Institute of the National Institutes of Health"},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2019,8,24]]},"DOI":"10.1080\/10428194.2019.1594217","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T06:34:58Z","timestamp":1559716498000},"page":"2356-2364","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Maximizing the effectiveness of oral therapies in lymphoid cancers: research gaps and unmet needs"],"prefix":"10.1080","volume":"60","author":[{"given":"Alix Y. L.","family":"Zackon","sequence":"first","affiliation":[{"name":"Winship Cancer Institute, Emory University, Atlanta, GA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy A.","family":"Ayers","sequence":"additional","affiliation":[{"name":"Winship Cancer Institute, Emory University, Atlanta, GA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine A.","family":"Yeager","sequence":"additional","affiliation":[{"name":"Winship Cancer Institute, Emory University, Atlanta, GA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary L.","family":"Somma","sequence":"additional","affiliation":[{"name":"Scientific and Research Programs, Lymphoma Research Foundation, New York, NY, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan W.","family":"Friedberg","sequence":"additional","affiliation":[{"name":"Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher R.","family":"Flowers","sequence":"additional","affiliation":[{"name":"Winship Cancer Institute, Emory University, Atlanta, GA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loretta J.","family":"Nastoupil","sequence":"additional","affiliation":[{"name":"MD Anderson Cancer Center, The University of Texas, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2019,6,4]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21357"},{"key":"CIT0002","first-page":"231","volume":"15","author":"Geynisman DM","year":"2013","journal-title":"Discov Med"},{"key":"CIT0003","unstructured":"Friedberg JW, Williams ME. Oral Therapies in Lymphoma: Opportunities and Challenges in Research and Treatment. A Lymphoma Research Foundation White Paper: Lymphoma Research Foundation; 2015."},{"key":"CIT0004","unstructured":"Friedberg JW, Williams ME. Adherence and Oral Therapies in Lymphoma and CLL. A Lymphoma Research Foundation White Paper: Lymphoma Research Foundation; 2018."},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2018.1482273"},{"key":"CIT0006","first-page":"152","volume":"130","author":"Tam CS","year":"2017","journal-title":"Blood"},{"key":"CIT0007","unstructured":"FDA. Duvelisib (COPIKTRA, Verastem, Inc.) for adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) www.fda.gov: U.S. Food & Drug Administration; 2018 [cited 2018 Nov 21]. Available from: https:\/\/www.fda.gov\/Drugs\/InformationOnDrugs\/ApprovedDrugs\/ucm621503.htm"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-08-595934"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2018.05.022"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.5363"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.95"},{"key":"CIT0012","volume-title":"Hematology\/oncology (cancer) approvals & safety notifications","author":"FDA","year":"2018"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805104"},{"key":"CIT0014","doi-asserted-by":"crossref","unstructured":"Leonard JP, Trn\u011bn\u00fd M, Izutsu K, et\u00a0al. A phase III randomized study of lenalidomide plus rituximab (R2) vs rituximab\/placebo in patients with relapsed\/refractory indolent non-Hodgkin lymphoma. 2018.","DOI":"10.1182\/blood-2018-99-110861"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-015-0224-3"},{"key":"CIT0016","unstructured":"US National Library of Medicine. Selinexor in initial or relapsed\/refractory Richter\u2019s transformation. ClinicalTrials.gov: U.S. National Library of Medicine; 2018 [cited 2019 Mar 22]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02138786"},{"key":"CIT0017","unstructured":"US National Library of Medicine. A phase 2b open-label study of selinexor (KPT-330) in patients with relapsed\/refractory Diffuse Large B-Cell Lymphoma (DLBCL). ClinicalTrials.gov: U.S. National Library of Medicine; 2018 [cited 2019 Mar 22]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02227251"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.7171"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0624"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-010-0103-6"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S106629"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.3087"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-196543"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-12-737346"},{"key":"CIT0025","volume-title":"Adherence to long-term therapies: evidence for action","author":"Sabat\u00e9 E","year":"2003"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.3610.3610"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2012.01.021"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-012-0172-7"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-017-2372-z"},{"key":"CIT0030","unstructured":"Aitken M, Kleinrock M. Global Oncology Trend Report: A Review of 2015 and Outlook to 2020. IMS Institute for Healthcare Informatics; 2016."},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.68.2856"},{"key":"CIT0032","first-page":"80","volume":"27","author":"Zafar SY","year":"2013","journal-title":"Oncology (Williston Park)"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0279"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.9123"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903396469"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1586\/14737140.2015.1014807"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.9.1469"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.6.1007"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv102"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-08-764712"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314583"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00915"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.2196\/mhealth.8349"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.17.00039"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1177\/1078155215608523"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2014.904281"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.2.356"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.6591"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)80257-4"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200725060-00004"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2019.1594217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T09:25:53Z","timestamp":1597569953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2019.1594217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,4]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,8,24]]}},"alternative-id":["10.1080\/10428194.2019.1594217"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2019.1594217","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-12-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}